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Background: We report a case of unsuccessful percutaneous mechanical thrombectomy in treatment of a
high-risk pulmonary embolism (PE). Pulmonary thromboemboli are commonly expected as a homogenous mass,
rich with red blood cell content, which respond well to percutaneous mechanical thrombectomy (PMT). Catheter-based
approach or surgical embolectomy are two treatment options that are usually considered for treatment of high-risk PE
when the thrombolytic therapy fails or it is contraindicated due to a patient’s persisting hemodynamic compromise.
Currently, selection criteria for PE treatment options are based mostly on the assessment of patient’s history. The aim of
this report is to highlight a possible treatment complication in PMT of structurally heterogeneous thrombotic mass due
to PMT inadequacy.
Case presentation: A 32 year-old male with polytrauma was admitted to an intensive care unit after a right-sided
nephrectomy and evacuation of retroperitoneal hematoma. The patient initial haemostatic disorder was improved
by administration of blood preparations, an anti-fibrinolytic agent and concentrates of fibrinogen. On the third
day he presented sudden onset of hemodynamic instability and was incapable of standard CTA diagnostic procedure.
Urgent and relevant investigations including transthoracic and transesophageal echocardiogram confirmed a high-risk
PE. PMT was performed due to contraindications for systemic thrombolysis. Long-term PMT was attempted using
aspiration with several devices. No major improvement was achieved in any of the treatments and the patient died.
Autopsy confirmed a large heterogeneous thrombotic mass in the pulmonary trunk folding to the right main artery.
Additional histological analysis revealed a high fibrin-rich content in the peripheral surroundings of the thrombus.
Conclusion: In the case, it was confirmed that the outcome of PMT was directly influenced by mechanical and
histological features of the thromboembolus in high-risk PE. Formation of a rather complex thromboembolus in
high-risk PE favors surgical embolectomy as the only life-saving treatment option. Current diagnostic imaging
techniques do not enable precise assessment of thrombi structure and are therefore unable to identify patients
who might benefit from PMT or open surgical embolectomy. Surgical backup treatment should be considered if
there are no contraindications in the event of a failed catheter intervention.
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An acute massive pulmonary thromboembolism, i.e., high
risk PE, represents the most severe form of pulmonary
embolism with mortality rates exceeding 20% irrespective
of treatment [1, 2]. High-risk PE can ultimately result in
sudden death secondary to massive obstruction of the
pulmonary bed (approximately 10% of PE cases). Clin-
ical presentation of high-risk PE is associated with
hemodynamic instability, persistent hypotension (with
hypotension defined as a sudden fall in systolic blood
pressure to <90 mmHg or more, or by ≥40 mmHg from
baseline) and cardiogenic shock [3, 4]. Standard manage-
ment of PE involves anticoagulant treatment, though sys-
temic thrombolysis is considered as a treatment of choice
in cases of worsening cardiovascular instability or rapid
respiratory failure [5–7]. Catheter-based approaches or
open surgical embolectomy are usually considered when
the thrombolytic therapy fails or it is contraindicated and
a patient has persisting hemodynamic compromise [8–
11]. PMT involves use of certain mechanical devices,
ultrasound, pressurized saline injection or suction to as-
pirate fragments of macerated emboli following other
thrombectomy techniques [12–16]. Mechanical thromb-
ectomy exposes a thrombus surface area after fragmenta-
tion and enables local intra-clot thrombolytic agents to
augment thrombolysis [17–24]. Although thrombolysis
and PMT facilitate rapid improvement in haemodynamics,
serious complications may occur, including bleeding, per-
foration or dissection of cardiovascular structures as well
as failure to respond to initial immediate management
[25]. Currently, selection criteria for PE treatment options,
i.e., systemic thrombolysis, PMT or open surgical embol-
ectomy, are based mostly on the assessment of patient’s
history.
The structure of thrombi may influence the outcome
of their resolution significantly [26]. Commonly, pul-
monary thromboemboli are composed of a fibrin mesh-
work with entrapped RBCs and an extracellular space
filled with serum, while platelets regroup into tight ag-
gregates mimicking a solid tissue structure, rich with
cellular proteins [27]. Histological characteristics of
thromboemboli may vary significantly ranging from a
homogenous to more complex and compacted throm-
botic mass, primarily due to various etiopathogenesis of
PE [28]. Contrary to the established knowledge that
acutely formed thrombi are composed mostly of RBC-
rich regions, rather complex histological characteristics
were found in approximately 75% of mechanically re-
trieved thrombi [29]. There is still lack of studies, which
would correlate thrombolytic or mechanical manage-
ment of high-risk PE with histological characteristics of
occluding thromboemboli.
The aim of this case report on PMT of the high-risk
PE is to highlight a correlation between histologicalcharacteristics of fibrin-rich thrombi and the perform-
ance of PMT.
Case presentation
A 32 year-old male was admitted to an intensive care
unit after right-sided nephrectomy, evacuation of retro-
peritoneal hematoma and removal of tamponade from
the abdominal cavity. The patient previously suffered
from polytrauma in the chest, abdomen and right hip.
Whole body CT excluded intracranial injury, however, it
showed a contusion of the right lung, a major laceration
of the right kidney, minor laceration of the right liver as
well as an extensive retroperitoneal hematoma along
with fractures of the left clavicle, first left rib and right
iliac crest. At admission the patient was sedated, analge-
sied and hemodynamically stable. After the consultation
with urologist and abdominal surgeon CT angiography
and embolization of the right renal artery were carried
out first. Subsequently, emergency surgery was per-
formed with removal of large retroperitoneal coagulum
and right-sided nephrectomy. Major bleeding occurred
from the vein cava inferior shortly after the removal of
retroperitoneal coagulum suggesting some vessel dam-
age during the accident. In order to stop the bleeding
and to perform haemostasis, the vein had to be tempor-
arily compressed. The patient was hemodynamically
stable at all times, however, due to major bleeding, blood
preparations were administered. He received totally 4
units of packed RBCs, 5 units of fresh frozen plasma, 1
unit of platelets, 2 g of Hemocoplettan (CSL Behring,
Germany), 1 g of transexsamic acid and 1500 ml of col-
loids. About 600 ml of blood volume was returned along
with the use of Cell Saver (Haemonetics, USA). The total
blood loss was estimated to be at least 2000 ml. Shortly
after the surgery the patient needed transfusions of fresh
frozen plasma and clotting factors as well as packed
RBCs due to continuation of the haemostatic disorder
with thrombocytopenia and prolonged aPTT. Laboratory
screening assays performed in the next two days showed
persistent thrombocytopenia, high-level of fibrinogen
with a strong increase of D-dimer, prolonged aPTT and
a low level of antithrombin. After the first two days, he
was translated to spontaneous breathing and eventually
extubated. On the third day, he presented sudden onset
of hemodynamic instability, therefore incapable of stand-
ard CTA diagnostic evaluation. Urgent and relevant
transthoracic and transesophageal echocardiograms were
performed, which showed a massive thrombus in the
pulmonary trunk along with the straining of the right
ventricle.
Percutaneous mechanical thrombectomy
PMT was performed due to its prompt availability and
patient’s contraindications for systemic thrombolysis.
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through the right transfemoral catheterization with an
insertion of a 10 F leading catheter. Angiography dem-
onstrated an extensive thrombotic mass in the pulmon-
ary trunk, expanding to the right basal and segmental
arteries, however, no major defect was detected in the
left pulmonary artery. Long-term PMT was attempted,
for approximately 70 min in total, using aspiration with
mechanical thrombectomy devices Aspirex 10 F, 6 F
(Straub Medical AG, Switzerland) and Rotarex 6 F
(Straub Medical AG, Switzerland), manual aspiration,
balloon dilatation and fragmentation with a pigtail. Dur-
ing the intervention 10.000 units of heparin was admin-
istered. No major improvement was achieved and the
patient became hemodynamically unstable. Local intra-
clot administration of 15 mg of Actylise (Boehringer
Ingelheim, Germany) was applied at the beginning of re-
suscitation, however, without any significant improve-
ment and the patient died.
Histology
Pulmonary thromboembolus was acquired within 48 h
after the unsuccessful PMT procedure in routine aut-
opsy where high-risk PE was confirmed as the main
cause of death. Three major samples obtained from a
large thromboembolic mass were carefully removed
from the surrounding tissue and rinsed with isotonic sa-
line of 0.9% w/v of NaCl, pH 7.4. The same samples
were subsequently fixated in 10% buffered formalin for
48 h. After the fixation they were cut longitudinally and
embedded in paraffin. Serial 5 μm thick cross-sections
were cut from each sample. Pathologic features were ini-
tially estimated using histological sections stained by
haematoxylin-eosin (HE), while an acid Picro-Mallory
(PM) stain was used to reveal fibrin layers (clear red),
RBCs (yellow) and the presence of connective tissue
(blue). Subsequently, the sections were immunohisto-
chemically stained against RBCs (GPA), platelet compo-
nents (CD61) and fibrin using monoclonal antibodies
(Anti-Human Glycophorin A, β-3 integrin Anti-Human
CD61 and Polyclonal Rabbit Anti-Human Fibrinogen,
DakoCytomation, Denmark). Monoclonal mouse anti-
human antibodies against Col I (Sigma Aldrich) were
used additionally to visualize a possible presence of col-
lagen inclusions in the thromboembolus. Immunohisto-
chemical staining was performed using a Ventana
Bench-Mark automatic stainer with a streptavidin-
biotin peroxidase complex and diaminobenzidinetetra-
hydrochloride as a chromogen.
Discussion
PMT techniques (aspiration, fragmentation and rheolytic
thrombectomy) are designed to optimize target-vessel
recanalization and to shorten the procedure time inlarge vessels or bypass grafts. Specifically, in high-risk
PE the rationale behind PMT is a rapid relief of a central
pulmonary occlusion. In our case, the angiographic out-
come of used PMT devices was strongly influenced by
the histological characteristics of the occluding throm-
boembolus. Massive occlusions demonstrate extremely
low recanalization rates as well as long recanalization
times without any significant improvement. Most plaus-
ible explanation why the morphology of the thrombus
influence the outcome of the initiated PMT is most
likely a high-protein (fibrin-rich) content in a structur-
ally heterogeneous thrombotic mass. This observation
could be supported by the results of autopsy, histology
and retrospective analysis of laboratory findings.
The autopsy (Fig. 1b and c) confirmed our assump-
tions that the occlusion of the pulmonary trunk along
with the right pulmonary artery was caused by a large,
highly heterogeneous, twisted and folded thrombotic
mass. Furthermore, the autopsy excluded any sign of a
leading catheter damage, which could suggest a PMT
malfunction. Additionally it excluded any signs of vein
cava inferior wall trauma, which could be caused due to
surgically performed haemostasis and could represent a
possible origin for thrombus formation. Macroscopic
cross-sections of representative samples of the throm-
boembolus showed thick white protein laminations, con-
centrated mainly in the peripheral surrounding, while
compacted RBC-rich regions were accumulated in the
central part of the thromboembolus. Histological ana-
lysis of the thromboembolus (Fig. 2) using conventional
non-specific HE, semi-specific trichrome PM and immu-
nospecific staining for GPA, CD61 and fibrin confirmed
that the high RBC content were found mainly in central
parts of the thromboembolus (yellow regions in Fig. 2c
and brown in Fig. 2d). On the contrary, large amounts
of a dense fibrin meshwork interspersed with moderate
platelet areas were found in peripheral regions of the
thromboembolus (brown in Fig. 2e and Fig. 2f ). Histo-
logical and immunohistochemical analysis revealed no
signs of early organization as well as no sign of large col-
lagen inclusions, which suggests that the formation of
thromboembolic impact occurred rather fast, i.e., in less
than three days [30].
The criteria for using PMT were in our case restricted
due to the patient’s presenting in hemodynamic shock
and contraindications for systemic thrombolysis. Several
PMT devices such as Aspirex, Rotarex, manual aspir-
ation, balloon dilatation and pigtail were used in at-
tempts of recanalization, however, all of them failed.
One of the reasons for that is a large accumulations of
fibrin and cellular components, which made the throm-
boembolus stiff/hard. The stiffness of the fibrin-rich
thromboembolus originates from a substantial fibrin
meshwork that reduced the performance of PMT devices
Fig. 1 Selective pulmonary angiogram (a) revealing massive
pulmonary thrombus (encircled symbolically in red line) causing a
central obstruction in the pulmonary trunk and in the right main
pulmonary artery. Marcophoto images (b, c) obtained during autopsy
confirming the presence of a large heterogeneous thrombotic mass in
the pulmonary trunk folding to the right pulmonary artery
Fig. 2 Gross morphology of a formaldehyde-fixated representative
sample of the heterogeneous thromboembolus (a). Histological
analysis in a cross-section of the same representative sample using
non-specific haematoxylin-eosin staining (b) and Picro-Mallory ((c),
RBC-rich regions appear yellow and fibrin clear red). Immunospecific
staining for glycophorin A ((d), RBCs appear brown), anti β-3 integrin
((e), platelets appear brown), anti-fibrin ((f), fibrin meshwork appears
brown) and anti-collagen ((g), no true positive reaction). Original
magnification: 2×
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Furthermore, the unusual properties of the fibrin-rich
thromboembolus (stiffness/noncompliance) can also ex-
plain why the thromboembolus was less susceptible to
fragmentation, thus preventing piecemeal thrombec-
tomy. In a case of partial fragmentation, it is expected
that the captured parts would not pass through the
guiding catheter tip due to their size and mechanical
properties.There is currently no widely accepted protocol for
PMT, however, a systematic review analyzing a variety of
PMT methods showed that they were all generally safe
and effective with no significant difference among the
methods and with low complication rates [32]. Up to
now, only a few cases of failed PMT are found in the
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resulting from multiple embolic events or due to the
presence of organized and adherent thrombi [33].
Etiopathogenesis of the rather complex fibrin-rich
thromboembolus could be attributed to a combination
of patient’s initial underlying disorder, i.e. politrauma
with large blood loss, following necessary surgery and
subsequently administrations of fibrinogen, blood trans-
fusions and anti-fibrinolytic drug. Laboratory screening
assays in the follow-up are in accordance with persistent
changes in the patient’s haemostatic functions such as
thrombocytopenia, strong increase in D-dimer and pro-
longed aPTT. Results of the laboratory tests suggest that
pathogenesis of DIC-associated disorder might have oc-
curred with a predominating thrombotic component, fa-
voring formation of the fibrin-rich thromboembolus.
It is rather unlikely that the structure of the throm-
boembolus was changed during the PMT procedure and
attempts of intra-clot lysis. Our observation is supported
with a post-mortem histological and immunohistochem-
ical analysis of the occluding thromboembolus. The ana-
lysis revealed no signs of early organization as well as no
signs of large collagen inclusions, along with a fibrin-
rich content. This suggests that the formation and
propagation of the thromboembolus occurred rather
fast, i.e., in less than three days, with a massive fibrino-
gen consumption.
Other than PMT, we found no major hemodynamic
improvement after the introduction of intra-clot admin-
istration of fibrin-specific thrombolytic agent. This ob-
servation is in agreement with results of in vitro
fibrinolysis, which suggest that dissolution of the fibrin-
rich clots proceeds at a rather slow rate due to an im-
peded progression of the local thrombolytic agent [34].
Current standard diagnostic imaging techniques do
not enable precise histological characterization of
thrombi in situ. As a result of that two different throm-
boemboli may show an identical angiographical profile,
however they would respond quite differently to PMT
due to their relevant properties that remained angio-
graphically undetected. On the other hand, advanced
multiparametric MRI already enables discrimination be-
tween cell-rich or protein-rich components of thrombi
[35]. Translation of advanced MR imaging techniques
from an experimental in vitro to clinical in vivo envi-
ronment, such as, free-breathing MRI techniques,
multiparametric MRI acquisition and application of
fibrin-specific MRI contrast agents could already enable
a more precise morphological and functional assessment
of thrombi and therefore ease treatment decision mak-
ing, i.e. PMT vs. surgical embolectomy [36–38]. Specific-
ally, in our case, a prompt use of advanced imaging
diagnostic tools, for example multiparametric MRI,
could enable right treatment decision so that the patientwould be treated by surgical embolectomy instead by
PMT. Nevertheless, a multidisciplinary approach is de-
sired to determine the best treatment for patients with
life-threatening PE. In the event of a failed catheter
intervention, surgical backup treatment should be con-
sidered if there are no contraindications.
Conclusion
We conclude that mechanical and histological features
of thromboembolus may directly influence the outcome
of PMT as shown in presented case report. Specifically,
in critically-ill patients formation of rather complex
thrombi may occur, favoring surgical embolectomy as
the only life-saving treatment option. Currently diagnos-
tic imaging lacks of more price assessment of thrombi
structure. Therefore, it is difficult to identify patients be-
tween the two treatment options, PMT or surgical em-
bolectomy. In the event of a failed PMT surgical backup
should be considered if there are no contraindications.
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